Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled time : 01:00 save search
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-17 (Crawled : 01:00) - alteritytherapeutics.com
ATHE | News | $2.15 6.97% 6.51% 27K
|
Health Technology
|
| O: -14.29%
H: 0.0%
C: 0.0%
disease neurology system meeting parkinson’s therapeutics
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA
Published: 2024-04-10 (Crawled : 01:00) - prnewswire.com
SWAV | $327.42 -0.02% -0.02% 1.2M
|
Health Technology
|
| O: -0.32%
H: 1.09%
C: 1.02%
KTRA | $0.1059 2.02% 1.98% 1.7M
|
Distribution Services
|
| O: -2.17%
H: 0.15%
C: -1.69%
ABIO | $3.29 2.49% 2.43% 220K
|
Health Technology
|
| O: 1.62%
H: 1.92%
C: 0.32%
Contineum Therapeutics Announces Pricing of Initial Public Offering
Published: 2024-04-05 (Crawled : 01:00) - globenewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
Published: 2024-03-28 (Crawled : 01:00) - prnewswire.com
AKBA | $1.38 -0.72% -0.72% 2.5M
|
Health Technology
|
| O: 10.27%
H: 0.4%
C: -25.91%
vafseo fda disease kidney anemia approval treatment dialysis
Everest Medicines Announces Singapore Health Sciences Authority Approves NEFEGAN® for the Treatment of Primary IgA Nephropathy in Adult Patients
Published: 2024-03-20 (Crawled : 01:00) - prnewswire.com
CALT | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: 0.0%
nefegan nephropathy health treatment sciences
Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer
Published: 2024-03-18 (Crawled : 01:00) - prnewswire.com
CALT | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: -4.04%
H: 3.27%
C: 3.04%
management medical
Trump Media SPAC Avoids Legal Roadblock on Way to Merger Vote – Mergers & Acquisitions
Published: 2024-03-07 (Crawled : 01:00) - spacfeed.com
ATMU A | $31.09 -3.45% 0.0% 2.2M
|
n/a
|
| O: 0.52%
H: 3.96%
C: 3.78%
SEEL | $0.322 -3.01% -3.11% 270K
|
Health Technology
|
| O: 6.19%
H: 5.0%
C: -3.33%
media acquisitions spac
Global Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report 2023-2030
Published: 2024-02-13 (Crawled : 01:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
report global trends therapeutics market
Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Published: 2024-02-08 (Crawled : 01:00) - globenewswire.com
TENX | $3.67 2.23% 2.18% 21K
|
Health Technology
|
| O: -64.03%
H: 9.16%
C: -1.17%
tnx-103 first treatment hypertension heart therapeutics study
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
Published: 2024-01-24 (Crawled : 01:00) - prnewswire.com
HRTX | $2.71 -2.17% -2.21% 1.8M
|
Health Technology
|
| O: 5.91%
H: 12.45%
C: 12.23%
zynrelef fda approval expansion therapeutics
Moore Kuehn, PLLC Encourages Xponential Fitness, Inc. Investors to Contact Law Firm
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
XPOF | News | $13.11 -0.53% 0.0% 600K
|
|
| O: 1.41%
H: 8.92%
C: 8.36%
BTAI | $2.56 -1.16% -1.17% 240K
|
Health Technology
|
| O: 0.94%
H: 3.41%
C: 0.31%
moore
US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.56%
H: 0.51%
C: 0.51%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.45%
H: 0.75%
C: 0.46%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 1.83%
H: 0.04%
C: -1.13%
kidney cancer novartis diagnostics therapeutics market
Rakovina Therapeutics Inc. Announces Q3 2023 Financial Results and Provides Corporate Update
Published: 2023-11-28 (Crawled : 01:00) - globenewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -2.8%
H: 0.19%
C: -0.16%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.72%
H: 0.52%
C: 0.16%
update therapeutics financial results
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Barclays PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCS, BCLYF
Published: 2023-11-27 (Crawled : 01:00) - prnewswire.com
BCLYF | $2.21 -10.14% 66K
|
Finance
|
| O: 0.0%
H: 0.28%
C: -1.97%
BCS | $9.24 1.54% 0.0% 21M
|
Finance
|
| O: -0.69%
H: 0.42%
C: -0.42%
AXSM | $65.81 -5.6% -5.93% 830K
|
Health Technology
|
| O: 0.1%
H: 5.89%
C: 5.83%
AHCO | $9.38 -0.53% -0.53% 920K
|
Finance
|
| O: 0.35%
H: 2.37%
C: 1.16%
deadline
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Barclays PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCS, BCLYF
Published: 2023-11-09 (Crawled : 01:00) - prnewswire.com
BCLYF | $2.21 -10.14% 66K
|
Finance
|
| O: -3.59%
H: 4.04%
C: -0.62%
PAYC 4 | $184.87 -1.07% 0.0% 610K
|
Technology Services
|
| O: 1.06%
H: 0.95%
C: -0.91%
BCS | $9.24 1.54% 0.0% 21M
|
Finance
|
| O: 0.9%
H: 0.59%
C: -1.19%
BCLI | $0.503 -6.99% -7.51% 1.1M
|
Health Technology
|
| O: -1.28%
H: 2.06%
C: -4.47%
deadline
Calliditas Presents Additional Data Analyses from the NefIgArd Phase 3 trial at the American Society of Nephrology (ASN) Kidney Week 2023
Published: 2023-11-07 (Crawled : 01:00) - prnewswire.com
CALT | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: -3.41%
H: 3.46%
C: 0.25%
kidney nefigard week trial
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Enviva Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EVA
Published: 2023-11-06 (Crawled : 01:00) - prnewswire.com
DLO | $15.18 -2.82% -2.9% 1.1M
|
Information
|
| O: 1.14%
H: 0.81%
C: -2.1%
EVA | $0.395 -3.64% 4.76% 300K
|
Process Industries
|
| O: 1.3%
H: 0.04%
C: -6.85%
SRPT | $116.59 -1.1% -1.12% 500K
|
Health Technology
|
| O: 4.47%
H: 1.98%
C: -1.72%
trusted deadline
Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon® Chinese Patient Data and to Hold Conference Calls
Published: 2023-10-27 (Crawled : 01:00) - prnewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.32%
H: 0.23%
C: -3.06%
CALT | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: 2.58%
H: 0.08%
C: -3.42%
nefecon conference kidney presentation chinese week
Technological Advancements and Research Efforts Propel Neuromuscular Disease Therapeutics Market Growth
Published: 2023-10-27 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -18.18%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -3.68%
H: 0.0%
C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.0%
H: 0.17%
C: -2.45%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.23%
H: 0.08%
C: -1.92%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: -0.59%
H: 0.15%
C: -1.79%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -15.73%
H: 0.0%
C: 0.0%
BCLI | $0.503 -6.99% -7.51% 1.1M
|
Health Technology
|
| O: 3.73%
H: 1.8%
C: -4.19%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.45%
H: 0.12%
C: -2.28%
propel disease research therapeutics growth market
ALERT: The M&A Class Action Firm Continues Investigating the Merger - ORTX, SRT, CHS, ICPT
Published: 2023-10-24 (Crawled : 01:00) - prnewswire.com
SRT | $4.42 1.14% 0.0% 0
|
Commercial Services
|
| O: -0.58%
H: 0.47%
C: 0.23%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.03%
H: 0.19%
C: -0.06%
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: 0.7%
H: 0.8%
C: 0.27%
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.